We found that in both tumour and stroma, MYH expression was low in the majority (74 % for tumour; 81 % for stroma) of PDAC patients in this cohort, and that expression did not correlate with survival (Fig. 3B-D). This evidence concerns the gene MUTYH and neoplasm.